Erectile Dysfunction (ED) Drugs Market Size to Accelerate at a Rapid CAGR of 3.2% from 2018 to 2026
Transparency Market Research (TMR) has published a new report titled, “ Erectile Dysfunction Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026 ” . According to the report, the global erectile dysfunction drugs market was valued at US$ 4.35 Bn in 2016 and is projected to decline at a CAGR of 3.2% from 2018 to 2026. The report states that the overall market revenue is expected to decline during the forecast period, owing to loss of patent exclusivity. Bayer’s Levitra/Staxyn (vardenafil) is scheduled to expire in 2018 and is expected to contribute to the decline in revenue. However, high prevalence of erectile dysfunction, rise in geriatric population across the globe, and patient compliance are expected to boost sales in the erectile dysfunction drugs market during the forecast period from 2018 to 2026. North America held the largest share of the global erectile dysfunction drugs market in 2017. The U.S. is the largest phar...